| Autor: |
Omrani, Osama, Hafezi-Bakhtiari, Nema, DeSouza, Peter, Nikola, Christos, Wong, Ken, Lansley, Joseph, Dhillon, Permesh, Makalanda, Levansri, Chan, Nathan, Harrison, Thomas, Andrews, Alex, Siow, Isabel, Lee, Keng Siang, Yeo, Leonard, Spooner, Oliver, Bhogal, Pervinder |
| Předmět: |
|
| Zdroj: |
Interventional Neuroradiology; Oct2024, Vol. 30 Issue 5, p663-671, 9p |
| Abstrakt: |
Stent-retriever based mechanical thrombectomy (MT) has gained wide acceptance as the treatment of choice for acute ischaemic stroke (AIS) caused by large vessel occlusion (LVO). The Embotrap 3 is the latest iteration within this class of device. We present our results using the new Embotrap 3 device. Materials and Methods: We performed a retrospective review of our prospectively maintained database to identify all patients treated with the Embotrap 3 stent-retriever between January 2021 and January 2022. We recorded the baseline demographics, NIHSS, ASPECT score and clot characteristics, first pass and final eTICI scores, complications and 90 day mRS. Results: One hundred and ten patients met the inclusion criteria, average age 69 ± 14 years, 50% were male (n = 55). The median NIHSS at presentation was 18 (range 3–30) and 58.2% received IV tPA prior to MT. The median ASPECT score on plain CT was 8 with average clot length 20.2 ± 14.8 mm (n = 93). The first pass effect (FPE) was seen in 41.8% of cases with modified FPE seen in 59.1%. A 24-hour CT scan (n = 97) showed median ASPECTs of 7. 43.8% of patients achieve mRS ≤ 2 at 90-day mRS (n = 64). Conclusion: The Embotrap 3 stent-retriever has a high rate of FPE and final recanalization in this real world cohort of patients. [ABSTRACT FROM AUTHOR] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
